Renin–angiotensin–aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels

Published: 7 January 2016
Author(s): I. Mikolasevic, L. Zaputovic, L. Zibar, I. Begic, M. Zutelija, A. Klanac, I. Majurec, T. Simundic, M. Minazek, L. Orlic
Issue: January 2016
Section: Original Article

We have analyzed the effects of renin–angiotensin–aldosterone system (RAAS) inhibitors on evolution of hemoglobin (Hb) and hematocrit (Htc) levels as well as on the evaluation of kidney graft function in stable renal transplant recipients (RTRs) in respect with initially higher or lower Hb and Htc values.